CAS 174630-04-7 Reversin 121

Send Inquiry
CAS 174630-04-7 Reversin 121
Details
CAS: 174630-04-7
Core structure: **Non-peptide small-molecule flavonoid derivative**, a highly selective P-glycoprotein (P-gp) inhibitor that reverses tumor multidrug resistance and increases intracellular concentration of chemotherapeutic drugs by competitively binding to the ATP-binding domain of P-gp and inhibiting its efflux function
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Reagent Dissolution and Storage Guide
Category
Small-molecule Drug Resistance Reverser / P-glycoprotein Inhibitor
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 174630-04-7 reversin 121 in China, also supports custom service. Welcome to wholesale bulk high quality cas 174630-04-7 reversin 121 from our factory. Contact us for more details.

 

Product name CAS:174630‑04‑7:Reversin 121
Description Reversin 121 is a highly active small‑molecule inhibitor of P‑glycoprotein. It specifically binds to P‑gp transporters highly expressed on tumor cell membranes, inhibits its ATP‑dependent drug efflux function, significantly increases the intracellular accumulation of chemotherapeutic drugs such as doxorubicin and paclitaxel, reverses the multidrug resistance phenotype, and enhances the cytotoxicity of chemotherapeutic drugs. It has strong reversal activity and weak off‑target effects, and is a classic tool compound for tumor multidrug resistance mechanism research and chemosensitizing drug development.
Purity (HPLC, %) 95%/98%/99%
Molecular formula C₂₁H₂₀O₆
Molecular weight (Da) 368.38
Structure type Small‑molecule flavonoid organic compound, non‑peptide

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Product Attribute Target
Reversin 121 Reversin 121; P-gp inhibitor 121 Multidrug resistance reversal, P-gp inhibition, Chemosensitization, Tumor drug resistance research, Small-molecule inhibitor, Non-peptide Flavonoid parent nucleus with side-chain modified P-gp binding domain C₂₁H₂₀O₆ 368.13 368.38 Non-peptide small molecule P-glycoprotein (P-gp)

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
SML-REV121 Yellow to orange-yellow crystalline powder Store at -20℃, sealed, dry, protected from light, nitrogen-protected, aliquoted; avoid repeated freeze-thaw cycles Stable for 1 month at 2-8℃ sealed & dry; ice pack shipping recommended Stable for 7 days at 4℃ under anhydrous conditions; easy to precipitate in aqueous solution, prepare freshly before use**Poor water solubility, requires organic solvents such as DMSO and DMF, extremely easy to precipitate in physiological buffer**. Small-molecule flavonoids prone to photodegradation and oxidation Stable for 2 years at -20℃ under dry, oxygen-free and light-proof conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
SML-REV121 Highly selective small-molecule P-gp inhibitor that reverses tumor multidrug resistance and significantly enhances chemotherapeutic cytotoxicity Reversin 121 inhibits the ATP hydrolase activity of P-glycoprotein by binding to its nucleotide-binding domain, blocks the ATP-dependent drug efflux process, thereby reduces the efflux of chemotherapeutic drugs by tumor cells, increases intracellular drug concentration, and restores the sensitivity of drug-resistant cells to chemotherapeutic drugs. It has high selectivity for P-gp, weak effect on other ABC transporters such as MRP and BCRP, and lower off-target toxicity. It is a core tool compound for studying ABC transporter function, tumor multidrug resistance mechanism and chemosensitization strategies. Tumor multidrug resistance, ABC transporter function, Chemosensitization research, Tumor pharmacology, Drug resistance mechanism validation, Small-molecule drug development P-glycoprotein (P-gp/ABCB1); ATP-dependent drug efflux pathway; Multidrug resistance reversal pathway

Hot Tags: cas 174630-04-7 reversin 121, China cas 174630-04-7 reversin 121 manufacturers, suppliers, factory, 137525-51-0, 1415456-99-3, 910463-68-2, CAS 1415456 99 3, Melanotan II, Semaglutide

Send Inquiry